IL-17AA/IL-17AF inhibitors(QuantX Biosciences)

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameIL-17AA/IL-17AF inhibitors(QuantX Biosciences)
Drug Alias Namedual IL-17A/IL-17F inhibitors(QuantX Biosciences)
ClassificationSmall molecules
Mechanisms of ActionInterleukin 17A inhibitorsInterleukin-17F inhibitors
TargetsInterleukin 17AInterleukin-17F
Therapy Area/IndicationsPsoriasisHidradenitis Suppurativa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuantX Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesQuantX Biosciences
Inactive CompaniesN/A
Active IndicationsPsoriasisHidradenitis Suppurativa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A